Neurology Disease Suppliers In Asia Middle East

RareStone Group is dedicated to building the first rare disease ecosystem in China to improve the lives of patients and families impacted by rare diseases, by bringing the best-in-the-world therapeutic solutions and comprehensive and sustainable ...

Lumosa Therapeutics is a clinical-stage pharmaceutical company dedicating to develop novel therapies and solutions for neurological and oncological diseases with urgent unmet medical need. Besides of using Lumosa's own technology platform in drug ...

Mesoblast is using its proprietary mesenchymal lineage cell technology platform to develop and commercialize innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care. ...

DIERS International GmbH was founded in Wiesbaden in 1996. The company founder, Dipl. Eng. Helmut Diers, first completed an international career with various globally operating medical technology companies. From the beginning, close scientific ...

Theranica develops advanced, clinically proven, safe and affordable digital therapeutics, addressing some of the world’s most prevalent neurological pain diseases. We harness a pain inhibition mechanism known as Conditioned Pain Modulation (CPM). ...

Subtle Medical develops vendor-neutral software solutions that improve image quality on regular and accelerated image protocols, allowing radiologists to expedite patient care. Our vision is that every human being has the opportunity for a timely ...

Kadimastem is a bio-pharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. ...

We develop robotic devices to make people’s lives better. H Robotics develops, manufactures, and distributes state-of-the-art rehabilitation solutions, including medical robots and data-driven, telemedicine offerings for people who suffer with ...